Skip to main content
PVCT logo

PVCT · Provectus Biopharmaceuticals, Inc. · Shareholders & Ownership

Track PVCT — free
$0.05 +0.00 (+0.00%) At close · Oct 22
Market Cap
$21.01M
Shares
420.28M
Volume · Oct 22 5211 Avg daily vol (3M) 118.31K

Every disclosed holder of PVCT in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns PVCT

13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positions
Holder group Shares % Out
Institutional (13F) 129,812 0.03%
Insiders (Forms 3, 4, 5) 0 0.00%
13D/G-only blocks 138,762,434 33.02%
Remaining 281,387,633 66.95%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 420,279,879, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of PVCT

# Holder Shares
1
Jeffrey Allen Morris
13G CIK 1959175 · Unknown · Aug 12, 2024
Rule 13d-1(c), passive investor
61,100,610
2
Pershing Edward
13D CIK 1689739 · Unknown · Jun 30, 2026
Item 4 purpose: not restated by this amendment, the earlier 13D's purpose stands
52,441,275
3
Dominic Rodrigues
13D CIK 1703719 · Unknown · Dec 2, 2025
25,220,549
4
HOME FEDERAL BANK OF TENNESSEE
13F CIK 1665446 · Unknown · Sep 30, 2026
100,000
5
Atlas Wealth LLC
13F CIK 1964106 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
19,620
6
Financial Symmetry Inc
13F CIK 2004843 · Unknown · Sep 30, 2026
10,191
7
HUNTINGTON NATIONAL BANK
13F CIK 49205 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
1

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 315545 CUSIP 74373P108 13F (30d) 2 filings 2 filers Visit website Investor relations